CY1111436T1 - Πολυστρωματικο συστημα χορηγησης φαρμακων με φραγμα εναντια στη ροη του υλικου ταμιευτηρα - Google Patents

Πολυστρωματικο συστημα χορηγησης φαρμακων με φραγμα εναντια στη ροη του υλικου ταμιευτηρα

Info

Publication number
CY1111436T1
CY1111436T1 CY20101101082T CY101101082T CY1111436T1 CY 1111436 T1 CY1111436 T1 CY 1111436T1 CY 20101101082 T CY20101101082 T CY 20101101082T CY 101101082 T CY101101082 T CY 101101082T CY 1111436 T1 CY1111436 T1 CY 1111436T1
Authority
CY
Cyprus
Prior art keywords
medicamental
laminated
fluid flow
system supply
medicinal fluid
Prior art date
Application number
CY20101101082T
Other languages
English (en)
Inventor
Rolf R Jansen
Dina J Coronado
Original Assignee
Alza Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corporation filed Critical Alza Corporation
Publication of CY1111436T1 publication Critical patent/CY1111436T1/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/02Adhesive plasters or dressings
    • A61F13/0203Adhesive plasters or dressings having a fluid handling member
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061Polyacrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/02Adhesive plasters or dressings
    • A61F13/0276Apparatus or processes for manufacturing adhesive dressings or bandages
    • A61F2013/0296Apparatus or processes for manufacturing adhesive dressings or bandages for making transdermal patches (chemical processes excluded)
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T156/00Adhesive bonding and miscellaneous chemical manufacture
    • Y10T156/10Methods of surface bonding and/or assembly therefor
    • Y10T156/1052Methods of surface bonding and/or assembly therefor with cutting, punching, tearing or severing
    • Y10T156/1082Partial cutting bonded sandwich [e.g., grooving or incising]

Abstract

Ένα πολυστρωματικό σύστημα χορήγησης φαρμάκων με ένα φράγμα κατάλληλλο για την χορήγηση των φαρμάκων μέσω της επιφάνειας του σώματος ενός ατόμου. Με την τοποθέτηση ενός φράγματος μεταξύ δύο παρακείμενων στρωμάτων αποφεύγεται η ακούσια ροή των φαρμάκων, λόγω της μεταρροής του ενός φαρμάκου της μήτρας (περίβλημα) μεταξύ των παρακείμενων στρωμάτων η μήτρα (περίβλημα) του συστήματος σε έναν ασθενή.
CY20101101082T 2005-05-13 2010-11-25 Πολυστρωματικο συστημα χορηγησης φαρμακων με φραγμα εναντια στη ροη του υλικου ταμιευτηρα CY1111436T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68090505P 2005-05-13 2005-05-13
US79023606P 2006-04-07 2006-04-07
EP06759664A EP1895994B1 (en) 2005-05-13 2006-05-12 Multilayer drug delivery system with barrier against reservoir material flow

Publications (1)

Publication Number Publication Date
CY1111436T1 true CY1111436T1 (el) 2015-08-05

Family

ID=36928681

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20101101082T CY1111436T1 (el) 2005-05-13 2010-11-25 Πολυστρωματικο συστημα χορηγησης φαρμακων με φραγμα εναντια στη ροη του υλικου ταμιευτηρα

Country Status (10)

Country Link
US (3) US8632800B2 (el)
EP (3) EP1895994B1 (el)
AT (1) ATE478659T1 (el)
CY (1) CY1111436T1 (el)
DE (1) DE602006016441D1 (el)
DK (1) DK1895994T3 (el)
HK (1) HK1157244A1 (el)
PL (1) PL1895994T3 (el)
PT (1) PT1895994E (el)
WO (2) WO2006124584A2 (el)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1895994T3 (pl) * 2005-05-13 2011-02-28 Alza Corp Wielowarstwowy system podawania leków z barierą zabezpieczającą przed wypływaniem materiału ze zbiornika
US8383149B2 (en) * 2005-09-23 2013-02-26 Alza Corporation High enhancer-loading polyacrylate formulation for transdermal applications
WO2007035941A2 (en) * 2005-09-23 2007-03-29 Alza Corporation Transdermal galantamine delivery system
US20080226698A1 (en) * 2007-03-16 2008-09-18 Mylan Technologies, Inc. Amorphous drug transdermal systems, manufacturing methods, and stabilization
ES2692437T3 (es) * 2007-08-13 2018-12-03 Abuse Deterrent Pharmaceutical Llc Fármacos resistentes al abuso, método de uso y método de preparación
WO2010042152A2 (en) * 2008-10-06 2010-04-15 Mylan Technologies, Inc. Amorphous rotigotine transdermal system
KR101317158B1 (ko) * 2011-02-18 2013-10-15 조선대학교산학협력단 갈란타민 또는 그의 염을 함유하는 경피흡수제제
ES2851175T3 (es) 2013-02-05 2021-09-03 Purdue Pharma Lp Formulaciones farmacéuticas resistentes a manipulación
WO2015021031A1 (en) 2013-08-05 2015-02-12 Cam Med Llc Conformable patch pump
KR101485822B1 (ko) * 2014-01-22 2015-01-23 주식회사 대웅제약 도네페질 또는 그의 염을 함유하는 경피흡수제제
US10449201B2 (en) * 2015-08-17 2019-10-22 Alpha To Omega Pharmaceutical Consultants, Inc. Transdermal and/or topical delivery system comprising clobazam
DE102018216244A1 (de) * 2018-09-24 2020-03-26 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit Barriereschicht
ES2936735B2 (es) * 2021-09-20 2023-11-29 Paterna Jesus Paterna Dispositivo para preparar manualmente sistemas terapéuticos transdérmicos y procedimiento

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3493657A (en) 1961-03-14 1970-02-03 Mozes Juda Lewenstein Therapeutic compositions of n-allyl-14-hydroxy - dihydronormorphinane and morphine
US3598123A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3598122A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3773955A (en) 1970-08-03 1973-11-20 Bristol Myers Co Analgetic compositions
GB1451994A (en) * 1973-07-20 1976-10-06 Smithe Machine Co Inc F L Method and apparatus for cutting and applying patches
US4214557A (en) * 1978-08-15 1980-07-29 Beach Corbett D Jr Pivoting wall type, four stroke, internal combustion, rotary engine
US4457933A (en) 1980-01-24 1984-07-03 Bristol-Myers Company Prevention of analgesic abuse
US4286592A (en) 1980-02-04 1981-09-01 Alza Corporation Therapeutic system for administering drugs to the skin
US4314557A (en) 1980-05-19 1982-02-09 Alza Corporation Dissolution controlled active agent dispenser
US4379454A (en) * 1981-02-17 1983-04-12 Alza Corporation Dosage for coadministering drug and percutaneous absorption enhancer
US4464378A (en) 1981-04-28 1984-08-07 University Of Kentucky Research Foundation Method of administering narcotic antagonists and analgesics and novel dosage forms containing same
US4588580B2 (en) 1984-07-23 1999-02-16 Alaz Corp Transdermal administration of fentanyl and device therefor
US4626539A (en) 1984-08-10 1986-12-02 E. I. Dupont De Nemours And Company Trandermal delivery of opioids
US4568343A (en) * 1984-10-09 1986-02-04 Alza Corporation Skin permeation enhancer compositions
US4806341A (en) 1985-02-25 1989-02-21 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration
US5538736A (en) * 1987-04-28 1996-07-23 Lts Lohmann Therapie-Systeme Gmbh Active substance-containing plaster for the controlled administration of active substances to the skin
US4983395A (en) * 1987-11-12 1991-01-08 Theratech Inc. Device for administering an active agent to the skin or mucosa
US4849224A (en) * 1987-11-12 1989-07-18 Theratech Inc. Device for administering an active agent to the skin or mucosa
GB8728294D0 (en) 1987-12-03 1988-01-06 Reckitt & Colmann Prod Ltd Treatment compositions
US5236714A (en) 1988-11-01 1993-08-17 Alza Corporation Abusable substance dosage form having reduced abuse potential
US5350581A (en) * 1989-12-14 1994-09-27 Pharmetrix Corporation Method for manufacturing transdermal devices
DE4010079A1 (de) 1990-03-29 1991-10-02 Lohmann Therapie Syst Lts Pharmazeutische formulierung zur behandlung des alkoholismus
US5149538A (en) 1991-06-14 1992-09-22 Warner-Lambert Company Misuse-resistive transdermal opioid dosage form
KR950701516A (ko) * 1992-05-13 1995-04-28 에드워드 엘. 만델 옥시부티닌의 경피 투여(Transdermal Administration of Oxybutynin)
DE4301783C1 (de) 1993-01-23 1994-02-03 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit Galanthamin als wirksamem Bestandteil
US6316439B1 (en) 1993-10-15 2001-11-13 Aventis Pharamaceuticals Inc. Galanthamine derivatives as acetylcholinesterase inhibitors
US6323195B1 (en) * 1993-10-15 2001-11-27 Aventis Pharmaceuticals Inc. Galanthamine derivatives as acetylcholinesterase inhibitors
US6323196B1 (en) 1993-10-15 2001-11-27 Aventis Pharmaceuticals Inc. Galanthamine derivatives as acetylcholinesterase inhibitors
DE19509663A1 (de) 1995-03-17 1996-09-19 Lohmann Therapie Syst Lts Verfahren zur Isolierung von Galanthamin
DE69614841T2 (de) * 1995-04-06 2002-04-11 Janssen Pharmaceutica Nv Verfahren zur Herstellung von Galanthaminderivate durch asymmetrische Reduktion
US5882676A (en) 1995-05-26 1999-03-16 Alza Corporation Skin permeation enhancer compositions using acyl lactylates
US5785991A (en) 1995-06-07 1998-07-28 Alza Corporation Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
US5693335A (en) 1995-06-07 1997-12-02 Cygnus, Inc. Skin permeation enhancer composition for use with sex steroids
GB9514821D0 (en) 1995-07-19 1995-09-20 Sod Conseils Rech Applic Galanthamine derivatives
GB9519268D0 (en) * 1995-09-21 1995-11-22 Chiroscience Ltd Preparation of alkaloids
GB9519267D0 (en) * 1995-09-21 1995-11-22 Chiroscience Ltd Preparation of alkaloids
EP0934078B1 (en) 1996-10-24 2002-12-18 Alza Corporation Permeation enhancers for transdermal drug delivery compositions, devices, and methods
SI1299104T1 (sl) 2000-02-08 2009-10-31 Euro Celtique Sa Oralne formulacije opioidnih agonistov, varne pred zlorabo
CN100508974C (zh) 2001-03-16 2009-07-08 阿尔扎公司 施用芬太尼的经皮贴剂
WO2002087482A1 (en) 2001-05-01 2002-11-07 Euro-Celtique Abuse resistant opioid containing transdermal systems
FR2826005B1 (fr) 2001-06-15 2004-07-16 Centre Nat Rech Scient Synthese totale de la galanthamine, de ses analogues et de ses derives
DE10129265A1 (de) * 2001-06-18 2003-01-02 Hf Arzneimittelforsch Gmbh Wirkstoff-Kombination zur medikamentösen Sucht- oder Rauschmitteltherapie
US8440220B2 (en) * 2002-04-23 2013-05-14 Durect Corporation Transdermal analgesic systems with reduced abuse potential
US8524272B2 (en) * 2003-08-15 2013-09-03 Mylan Technologies, Inc. Transdermal patch incorporating active agent migration barrier layer
EP1898891A2 (en) 2005-05-13 2008-03-19 Alza Corporation Multilayer drug delivery system with barrier against antagonist exposure
PL1895994T3 (pl) 2005-05-13 2011-02-28 Alza Corp Wielowarstwowy system podawania leków z barierą zabezpieczającą przed wypływaniem materiału ze zbiornika

Also Published As

Publication number Publication date
PL1895994T3 (pl) 2011-02-28
US20060257462A1 (en) 2006-11-16
DK1895994T3 (da) 2010-12-20
HK1157244A1 (en) 2012-06-29
DE602006016441D1 (de) 2010-10-07
EP2316437A1 (en) 2011-05-04
US20140130973A1 (en) 2014-05-15
US20060257461A1 (en) 2006-11-16
PT1895994E (pt) 2010-12-03
EP1895994A2 (en) 2008-03-12
WO2006124584A3 (en) 2007-04-19
EP1895994B1 (en) 2010-08-25
WO2006124585A2 (en) 2006-11-23
US8632800B2 (en) 2014-01-21
WO2006124585A3 (en) 2007-05-03
ATE478659T1 (de) 2010-09-15
EP1895995A2 (en) 2008-03-12
EP2316437B1 (en) 2014-07-30
WO2006124584A2 (en) 2006-11-23

Similar Documents

Publication Publication Date Title
CY1111436T1 (el) Πολυστρωματικο συστημα χορηγησης φαρμακων με φραγμα εναντια στη ροη του υλικου ταμιευτηρα
WO2006124749A3 (en) Multilayer drug delivery system with barrier against antagonist exposure
WO2010042471A3 (en) Medical devices for delivery of therapeutic agents to body lumens
BRPI0514834B8 (pt) processo de montagem de dispositivos de envio de fármaco e dispositivo de envio de fármaco
WO2009045784A3 (en) Disposable infusion device layered structure
WO2011049744A3 (en) Microclimate management system
WO2007115039A3 (en) Multi-cartridge fluid delivery device
WO2007108970A3 (en) Infusion device with piston pump
WO2010029551A3 (en) Methods and devices for tailoring a bolus delivery pattern
ATE419842T1 (de) Abgabevehikel mit nanoteilchen
SMAP200900075A (it) Dispositivi terapeutici ibridi impiantabili
ATE550053T1 (de) Laminierte patienteninfusionsvorrichtung
AR063958A1 (es) Metodos para administrar medicaciones para la perdida de peso
WO2006133101A3 (en) Agent delivery system
ECSP088709A (es) Dispositivo de inyeccion con un sensor capacitivo de proximidad
DE602005009121D1 (de) Keramischer Verbundkörper mit intergrierter nachgiebiger Verschleissschicht
ES2571854T3 (es) Dispositivo de suministro montable en superficie
GB2464902A (en) Needle array assembly and method for delivering therapeutic agents
EP1827932A4 (en) LIQUID DISPENSING SYSTEM COMPRISING A LIQUID CIRCUIT PROVIDED WITH A STERILE RETAINING VALVE CONNECTOR
DE602005027059D1 (de) Polymer-füllstoff-komposite für die kontrollierte abgabe von therapeutischen mitteln aus medizinischen artikeln
HK1142270A1 (en) Silibinin component for the treatment of hepatitis
CL2014001478A1 (es) Pelicula de capas multiples libre de capa metalica, que comprende una capa exterior de al menos un polimero de olefina termoplastica, capa de agente de adherencia, capa de al menos una poliamida, capa de barrera de gas, capa de poliamida, adyacente a la anterior, y capa exterior de poliamida; uso; cuerpo ascencional; y globo.
BR112015026668A2 (pt) auxílio de fluxo para estrutura de infusão, estrutura de infusão com auxílio de fluxo, bem como método para a infiltração de material de fibra com resina
ECSP099828A (es) Uso de ranolazina para peptido natriuretico tipo-cerebral elevado
CL2008003133A1 (es) Uso de albumina humana para la preparacion de un medicamento para el tratamiento de desordenes cognitivos en pacientes de alzheimer, donde el medicamento se encuentra en forma de solucion para recambio plasmatico y/o perfusion intravenosa.